Tag Archives: Sales

J&J’s Darzalex pads blockbuster sales with another myeloma nod in new patients

Johnson & Johnson multiple myeloma drug Darzalex hasn’t stopped rolling since hitting the market. After picking up its first nod in previously untreated patients last May, the drug added a second indication in new patients on Thursday—and its sixth overall. The FDA cleared the product in combination with Celgene’s Revlimid and dexamethasone for patients who… Read More »